Skip to content
ITIF Logo
ITIF Search

Commentary

Setting the Policy Agenda on Innovation Issues

  • Alongside our in-depth policy reports, ITIF’s long-running Innovation Files blog serves as a forum where analysts provide quick takes, quips, and commentary on the latest in technology and innovation policy.
  • Other blogs from ITIF include In the Arena, Rob Atkinson’s notes on the battle of ideas (also on Substack at policyarena.org), plus special series, such as The Brussels Effect, examining how the EU exports its regulatory agenda; Defending Digital, examining spurious critiques of the tech industry; and Innovate4Health, covering the intersection between intellectual property and life sciences innovation.
  • ITIF analysts also frequently contribute op-eds and commentary pieces to leading publications around the world.

November 17, 2026|Op-Eds & Contributed Articles

Put Korean Consumers and Small Businesses First in the Platform Debate

The Online Platform Fairness Bill and special legislation for food delivery apps would weaken the services Korean businesses use to grow and that consumers count on every day by piling restrictions on large platforms and disproportionately burdening U.S. technology companies.

November 16, 2026|Blogs

Congress Has Two Very Different Bipartisan Paths on AI

Congress faces two competing bipartisan approaches to AI policy: one focused on restricting technology companies and AI development, and another focused on accelerating innovation and adoption. Rather than prioritizing restrictions, lawmakers should pursue a pro-innovation agenda that combines sensible safeguards with investments in research, infrastructure, and workforce development to strengthen U.S. competitiveness and deliver tangible benefits to Americans.

November 16, 2026|Blogs

Fact of the Week: China’s Trade Surplus Surpasses $1 Trillion in Just 10 Months

China’s trade surplus reached a staggering $1.04 trillion in the first 10 months of 2026, surpassing the $1 trillion threshold for the second consecutive year and reaching the milestone one month earlier than in 2025.

November 16, 2026|Blogs

Tracking Pax Silica’s Evolution: A Timeline

Major agreements, new participants, and key diplomatic and industrial milestones in the U.S.-led Pax Silica initiative, which aims to secure global supply chains that underpin AI and other advanced technologies.

November 12, 2026|Blogs

Don't Let China's Espionage Become America's Own Goal

An alleged Chinese espionage operation involving Nvidia’s former CEO has disrupted the company and fueled calls for tighter AI chip export restrictions. But sweeping new restrictions could further weaken American semiconductor companies and benefit Chinese competitors, making targeted enforcement a better approach.

November 9, 2026|Blogs

Fact of the Week: AI Adoption for Cybersecurity More Than Doubled Across OECD Enterprises Between 2021 and 2025

The share of enterprises using AI to address these cybersecurity challenges more than doubled between 2021 and 2025, reaching 5.3 percent, or approximately one-quarter of all enterprises using AI.

November 9, 2026|Blogs

Will Delivery-App Fee Caps Help Korea’s Small Restaurants?

South Korea should reject fee caps that could weaken services and growth opportunities, enforce existing competition law, and help restaurants adopt technologies that reduce operating costs and improve productivity.

November 5, 2026|Blogs

Better Federal Statistics Are Needed to Understand AI's Impact on Work

Policymakers lack the comprehensive data needed to understand how AI is affecting employment, wages, productivity, and the tasks workers perform. To close these gaps, federal statistical agencies should improve AI-related data collection, link technology adoption to employment outcomes, and make better use of private-sector data

November 5, 2026|Blogs

Technological Innovation Is Everything

The West must once again embrace technological progress and mount a robust intellectual attack on the forces of stasis. The alternative is decline.

November 2, 2026|Blogs

Fact of the Week: China Approved 94 Novel Oncology Drugs From 2020 to 2025, Surpassing the United States’ 87

From 2020 to 2025, China's National Medical Products Administration (NMPA) approved 94 novel oncology drugs, surpassing the 87 approved by the U.S. Food and Drug Administration (FDA).

Back to Top